Skip to main content
Clinical Trials/NCT01492075
NCT01492075
Completed
Phase 4

Phase IV Study of Postoperative Pain Management

Örebro University, Sweden1 site in 1 country40 target enrollmentJanuary 2008

Overview

Phase
Phase 4
Intervention
PCRA (Intermittent injection)
Conditions
Abdominal Hysterectomy
Sponsor
Örebro University, Sweden
Enrollment
40
Locations
1
Primary Endpoint
Morphine consumption
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The investigators hypothesis is that patient controlled local anesthetics administered intraabdominally are more efficacious compared to continuous infusion in reducing postoperative pain and morphine consumption.

Detailed Description

Open abdominal hysterectomy is a common procedure performed for many benign and malignant gynaecological diseases and is associated with moderate to severe pain. Traditional methods for postoperative pain management include patient controlled intravenous analgesia (PCA) using morphine, epidural analgesia and spinal analgesia with opiates but recently, even local aesthetic (LA) has been used intra-abdominally and into the abdominal wall. Although epidural analgesia may be considered by some to be gold standard for pain relief following abdominal surgery, a recent publication and past experience over several years may question the use of invasive techniques for lower abdominal surgery. Thus, there is a trend towards movement from central blocks towards other non-invasive methods for pain relief. PCA with morphine is now commonly used for management of pain following major surgery and compared to central blocks, has advantages in being relatively safe, easy to use and associated with a high degree of patient satisfaction. However, the large doses of morphine necessary to ensure adequate postoperative analgesia means that side effects such as postoperative nausea and vomiting (PONV), tiredness, pruritus, headache and constipation may be a major problem in this group of patients. Therefore, alternative techniques to reduce morphine requirements are increasingly being used. These include the use of paracetamol, non-steroidal anti-inflammatory drugs (NSAID) and recently local anaesthetics (LA). The latter have been found to result in morphine sparing by 30 - 40 % and even a reduction in postoperative nausea (PON). LA infused intraperitoneally is safe and effective and a recent study showed that using 12.5 mg/h levobupivacaine could attain adequate analgesia. Thus, efficacy of LA has been established as well as the dose. However, the method of administration of LA intraperitoneally remains unclear. This study is designed with the primary aim of studying whether morphine consumption can be reduced postoperatively using the patient-controlled administration system for intraperitoneal LA compared to a continuous infusion, and whether this translates into improved recovery parameters or reduced side effects and improved patient satisfaction.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
June 2010
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Örebro University, Sweden
Responsible Party
Principal Investigator
Principal Investigator

Anil Gupta

Associate Professor

Örebro University, Sweden

Eligibility Criteria

Inclusion Criteria

  • 18 -65 year old patients undergoing open abdominal hysterectomy.
  • ASA I - II (Appendix 1).
  • Have signed and dated Informed Consent.
  • Willing and able to comply with the protocol for the duration of the trial.

Exclusion Criteria

  • Patients undergoing open abdominal hysterectomy due to suspected cancer.
  • Patients with chronic pain who are taking analgesics regularly.
  • Allergy to components in levobupivacaine (Chirocaine)/Saline (Sodium Chloride).
  • Participation in other clinical trials.

Arms & Interventions

Continuous infusion

Continuous infusion of LA intraabdominally

Intervention: PCRA (Intermittent injection)

PCRA (Intermittent injection)

Patient controlled LA intraabdominally

Intervention: PCRA (Intermittent injection)

Outcomes

Primary Outcomes

Morphine consumption

Time Frame: 0-24 h

Total morphine consumption 0 - 24 h postoperatively

Secondary Outcomes

  • Home discharge(0-10 days)
  • Postoperative pain(0 - 48 h postoperatively)
  • PONV(0 - 48 h postoperatively)

Study Sites (1)

Loading locations...

Similar Trials